Programmed cell death ligand‐1 (PD‐L1) in tumor tissue is considered a biomarker because HNSCC with positive PD‐L1 expression is associated with improved OS with PD‐1 inhibitors [2]. The gene discussed is CD274; the disease is neoplasm.